| D011247 |
Pregnancy |
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. |
Gestation,Pregnancies |
|
| D011261 |
Pregnancy Trimester, First |
The beginning third of a human PREGNANCY, from the first day of the last normal menstrual period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation. |
Early Placental Phase,Pregnancy, First Trimester,Trimester, First,Early Placental Phases,First Pregnancy Trimester,First Pregnancy Trimesters,First Trimester,First Trimester Pregnancies,First Trimester Pregnancy,First Trimesters,Phase, Early Placental,Phases, Early Placental,Placental Phase, Early,Placental Phases, Early,Pregnancies, First Trimester,Pregnancy Trimesters, First,Trimesters, First |
|
| D005189 |
False Positive Reactions |
Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed) |
False Positive Reaction,Positive Reaction, False,Positive Reactions, False,Reaction, False Positive,Reactions, False Positive |
|
| D005260 |
Female |
|
Females |
|
| D005323 |
Fetal Monitoring |
Physiologic or biochemical monitoring of the fetus. It is usually done during LABOR, OBSTETRIC and may be performed in conjunction with the monitoring of uterine activity. It may also be performed prenatally as when the mother is undergoing surgery. |
Monitoring, Fetal,Fetal Monitorings,Monitorings, Fetal |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D006908 |
Hydroxyprogesterones |
Metabolites or derivatives of PROGESTERONE with hydroxyl group substitution at various sites. |
|
|
| D000033 |
Abortion, Threatened |
UTERINE BLEEDING from a GESTATION of less than 20 weeks without any CERVICAL DILATATION. It is characterized by vaginal bleeding, lower back discomfort, or midline pelvic cramping and a risk factor for MISCARRIAGE. |
Threatened Miscarriage,Miscarriage, Threatened,Threatened Abortion,Threatened Abortions,Threatened Miscarriages |
|
| D000077713 |
17 alpha-Hydroxyprogesterone Caproate |
Hydroxyprogesterone derivative that acts as a PROGESTIN and is used to reduce the risk of recurrent MISCARRIAGE and of PREMATURE BIRTH. It is also used in combination with ESTROGEN in the management of MENSTRUATION DISORDERS. |
17 alpha-Oxyprogesterone Capronate,17-Hydroxyprogesterone Capronate,17-alpha-Hydroxy-Progesterone Caproate,Delalutin,Hydroxyprogesterone Caproate,Hydroxyprogesterone Hexanoate,Makena,Neolutin,Oxyprogesterone Caproate,Prolutin Depot,Proluton Depot,17 Hydroxyprogesterone Capronate,17 alpha Hydroxy Progesterone Caproate,17 alpha Hydroxyprogesterone Caproate,17 alpha Oxyprogesterone Capronate,Caproate, 17-alpha-Hydroxy-Progesterone |
|
| D000328 |
Adult |
A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. |
Adults |
|